Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2017 Jul 28;7:6835. doi: 10.1038/s41598-017-07047-5

In vivo Raman spectral analysis of impaired cervical remodeling in a mouse model of delayed parturition

Christine M O’Brien 1,2, Jennifer L Herington 3, Naoko Brown 3, Isaac J Pence 1,2, Bibhash C Paria 3, James C Slaughter 4, Jeff Reese 1,2,3,5,#, Anita Mahadevan-Jansen 1,2,✉,#
PMCID: PMC5533720  PMID: 28754971

Abstract

Monitoring cervical structure and composition during pregnancy has high potential for prediction of preterm birth (PTB), a problem affecting 15 million newborns annually. We use in vivo Raman spectroscopy, a label-free, light-based method that provides a molecular fingerprint to non-invasively investigate normal and impaired cervical remodeling. Prostaglandins stimulate uterine contractions and are clinically used for cervical ripening during pregnancy. Deletion of cyclooxygenase-1 (Cox-1), an enzyme involved in production of these prostaglandins, results in delayed parturition in mice. Contrary to expectation, Cox-1 null mice displayed normal uterine contractility; therefore, this study sought to determine whether cervical changes could explain the parturition differences in Cox-1 null mice and gestation-matched wild type (WT) controls. Raman spectral changes related to extracellular matrix proteins, lipids, and nucleic acids were tracked over pregnancy and found to be significantly delayed in Cox-1 null mice at term. A cervical basis for the parturition delay was confirmed by other ex vivo tests including decreased tissue distensibility, hydration, and elevated progesterone levels in the Cox-1 null mice at term. In conclusion, in vivo Raman spectroscopy non-invasively detected abnormal remodeling in the Cox-1 null mouse, and clearly demonstrated that the cervix plays a key role in their delayed parturition.

Introduction

Pregnancy, labor, and the delivery of offspring (parturition) are highly regulated processes in all species. However, the mechanisms underlying the progression to term or preterm birth and onset of labor remain incompletely understood. Spontaneous preterm birth is considered a clinical syndrome that has multiple causes, including infection, cervical insufficiency, uterine overdistension, and others1. In all instances, cervical remodeling and dilation are required for successful expulsion of the fetus2. The cervix is endowed with important structural properties that ensure a tightly closed womb until the fetus is ready for delivery, and to act as a barrier against external infection. At the beginning of pregnancy, the cervix is a stiff, rigid cylinder with a highly cross-linked extracellular matrix that provides mechanical strength to maintain cervical closure2, 3. Over the course of pregnancy, this collagen-dense matrix is transformed into a compliant structure that allows passage of a fetus. Normal cervical remodeling during pregnancy involves a significant transition in mature to immature collagen cross-links4, a reduction in proteoglycans which control packing of collagen fibrils, a significant increase in the glycosaminoglycan hyaluronan5, and a significant increase in tissue hydration6, 7. Circulating as well as local hormone/endocrine levels are known to orchestrate these cervical changes3, 811, but a full understanding remains elusive.

Cyclooxygenase (Cox)-derived prostaglandins (PGs) serve as key signaling molecules during pregnancy1214. PGF2α plays an important role in the involution of the ovarian corpus luteum (luteolysis) in mice and subsequent decline in progesterone signaling leading to uterine contractions12, 15, 16. However, there is conflicting evidence for PGs as mediators of cervical ripening. Topical prostaglandin E (PGE) application is a potent stimulus for the induction of cervical ripening in women and animal models9, 1720, and PGs are required for cervical maturation during inflammation-induced preterm birth in mice21. Conversely, expression of Cox-1 and Cox-2 enzymes in the cervix is not increased at term in normal mouse models of pregnancy and neither are the concentrations of PGs or their receptors21. Furthermore, PG concentrations in cervical mucus do not increase prior to parturition in women2224. In addition, seminal fluid has high levels of PGs but has not been shown to promote cervical ripening25. A greater understanding of PG-mediated changes in the cervix is needed to clearly understand normal remodeling physiology and reduce adverse pregnancy outcomes.

Classical research approaches for investigating physiology are too invasive to be used in pregnant women; therefore, animal models inform much of our current knowledge regarding hormone/endocrine factors in pregnancy and cervical maturation26, 27. Two cyclooxygenase isoforms, Cox-1 and Cox-2, are responsible for catalyzing arachidonic acid to form prostaglandin H2 (PGH2), which is promptly converted by various synthases into specific PG species. Cox-1 is generally considered a constitutively expressed enzyme, whereas Cox-2 is induced in response to inflammation and other stimuli but is otherwise not active during pregnancy. Mice lacking the gene encoding Cox-1 (Ptgs1) exhibit delayed parturition12, 13, 28, 29. Previous reports in mice suggest that the absence of prostaglandins normally produced by Cox-1 prevent luteolysis and therefore the fall in circulating progesterone, thereby explaining the delay in parturition29. However, recent work from our group has shown that the uterus contracts normally in Cox-1 null mice30, leaving the reason for parturition delay unanswered. Herein, we hypothesized that abnormal cervical maturation, rather than impaired uterine contractility, plays a key role in the parturition delay of Cox-1 knockout (KO) mice.

To investigate cervical remodeling in Cox-1 KO mice throughout parturition, we employed a non-invasive method capable of probing the cervical microenvironment longitudinally in vivo. In the past decade, numerous innovative cervical assessment tools that span optical, acoustic, electrical, and direct mechanical approaches have been developed2, 31, 32. These tools have already improved our understanding of cervical remodeling in term and preterm birth. A few of these techniques are directly sensitive to biochemical composition. Fluorescence spectroscopy has been used to measure collagen concentration and solubility in women and animal models33, 34, which has consistently shown decreasing fluorescence intensity throughout pregnancy. Diffuse reflectance spectroscopy has measured significant increases in water and decreases in hemoglobin after application of prostaglandins for cervical ripening35, as well as changes in optical properties based on hormonal status36 and stage of pregnancy37. Second harmonic generation, an optical imaging method that probes fibrillar collagen, has confirmed increasing collagen dispersion throughout pregnancy in ex vivo human38 and mouse studies39, 40. More recently, optical coherence tomography was used to measure the three dimensional structure of collagen fibrils in the human uterine cervix, and found higher dispersion in excised pregnant tissues than non-pregnant samples41. These studies have yet to be performed in vivo, but contribute to increasing our understanding of collagen’s role in cervical remodeling during pregnancy.

In this paper, we present the application of Raman spectroscopy, a real time light-based approach that probes biochemical information of tissues in vivo, to study the pregnant cervix. Raman spectroscopy measures inelastically scattered photons generated by light interaction with molecular bonds. Each molecule has specific vibrational frequencies, and Raman-scattered light can be analyzed to determine the type of molecules present in any target tissue. Raman spectroscopy is sensitive to proteins, water, nucleic acids, lipids, and carbohydrates, and measures these markers simultaneously with high specificity4245. Raman spectroscopy was first applied to the in vivo cervix in the context of cervical dysplasia detection46. While conducting optimization of cervical dysplasia detection algorithms, it was discovered that Raman spectroscopy is sensitive to the effects of hormonal status on healthy cervical tissue4749. These findings led to the investigation of longitudinal biochemical changes that can be measured by Raman spectroscopy in the cervix during pregnancy in vivo, both in mouse models and human subjects31, 50.

The goal of this study was to non-invasively test the hypothesis that cervical remodeling, rather than uterine contractility, is impaired in Cox-1 KO mice and contributes to their delayed parturition phenotype. In vivo Raman spectroscopy was used to determine whether biochemical differences exist in the cervix of Cox-1 KO mice during pregnancy compared to wild type (WT). Additionally, we examined whether Raman spectra could be correlated with changes in biomechanical properties of the cervix including stiffness and distensibility in WT and Cox-1 KO mice. Finally, ex vivo biochemical assays were performed to validate results obtained from in vivo Raman spectroscopy.

Results

The uterus contracts normally during delayed parturition in Cox-1 KO mice

Examination of Cox-1 (Ptgs1) and Cox-2 (Ptgs2) messenger ribonucleic acid (mRNA) expression on the day of expected delivery (day 19) in WT mice (Fig. 1A ) revealed strong Cox-1 expression in the uterine luminal epithelium (LE) but low expression in the cervix; Cox-2 expression was low throughout the lower uterine segment. The timing of delivery was significantly delayed (p = 0.0001) in Cox-1 KO compared to WT mice (Fig. 1B). Despite strong Cox-1 expression in the uterus, representative tracings from ex vivo spontaneous uterine contractility experiments show that contraction patterns (Fig. 1C), and contractile activity (area under the curve of contractions per unit time) did not differ between WT and Cox-1 KO uteri on gestation day 15, 19, or comparison of WT day 19 versus Cox-1 KO day 20 (Fig. 1D). Thus, normal uterine function during delayed parturition suggests that the cervix may contribute to the delay, providing motivation for studying cervical remodeling in this model.

Figure 1.

Figure 1

Cox-1 expression in the pregnant mouse uterus, and the effect of global Cox-1 deletion on parturition and uterine contractility. (A) In situ hybridization of 35S-labeled Cox-1 and Cox-2 in WT day 19 mouse uterus. (B) Timing of delivery was recorded from pregnant WT and Cox-1 KO mice (*p = 0.0001). (C) Representative ex vivo contractility tracings of myometrial strips from pregnant mice on the indicated days of pregnancy. (D) Recordings of myometrial contractility (n = 5–11 mice per group) were analyzed for area under the curve (AUC). Mean ± SEM.

Raman spectral signatures from wild type and Cox-1 KO cervices deviate at the time of parturition

An approach for using Raman spectroscopy to assess the biochemical status of the cervix over time in WT and Cox-1 KO mice was developed. Raman spectra were acquired in vivo from the cervix of non-gravid (NG) and pregnant WT and Cox-1 KO mice using a portable Raman spectroscopy system (Fig. 2A–E). Measurements were taken from multiple sites on the ectocervix with the aid of a small speculum (Fig. 2B,C) for visualizing the probe location. A custom-built fiber optic Raman probe was used for spectral acquisition and a 3 second integration time was used for each spectrum. Average peak-normalized spectra (normalized to 1440 cm−1 peak for spectral visualization purposes only, all subsequent statistical analysis was performed on non-normalized spectra) were plotted for each mouse model over the course of pregnancy (n = 8–10 mice per group, per time point) (Fig. 2F,G). Regions of interest (gray bands, Fig. 2F,G) that showed maximum differences were identified for further analysis (Figs 34).

Figure 2.

Figure 2

In vivo Raman spectroscopy system for cervical assessment during pregnancy. (A) Illustration showing the placement of the Raman spectroscopy fiber optic probe against the ectocervix of the mouse. (B) Mouse cervix visualized using a speculum. (C) In vivo Raman spectroscopy during measurement of mouse cervix. (D) Raman spectroscopy fiber optic probe. (E) Image of in vivo Raman spectroscopy system. Average Raman spectra from different time points during pregnancy in WT (F) and Cox-1 KO (G) mice. Gray boxes indicate regions that were highlighted in Figs 34.

Figure 3.

Figure 3

Raman spectral bands change with pregnancy and are delayed in the Cox-1 KO mouse compared to WT. Average Raman spectra from the 1265 cm−1 peak (blue dashed line) and 1304 cm−1 peak (blue dashed line) during different time points of pregnancy in WT (A) and Cox-1 KO (B) mice. (C) Mean ± SEM of the 1304 cm−1 to 1265 cm−1 peak ratio as a function of gestation in WT and Cox-1 KO mice (p < 0.05). (D) Modeled longitudinal trajectories of the 1304 cm−1 to 1265 cm−1 Raman peak ratio.

Figure 4.

Figure 4

Raman spectra reveal delayed remodeling in the Cox-1 KO mouse at term. Mean ± SEM (A) and modeled longitudinal trajectories (B) of the 1657 cm−1 to 1440 cm−1 peak ratio. Mean ± SEM (C) and modeled longitudinal trajectory (D) of the non-negative least squares model collagen coefficient as a function of gestation in WT and Cox-1 KO mice.

Ratios of multiple Raman peaks were calculated and plotted as a function of gestation day and mouse model to quantitatively evaluate spectral changes over time. Of the various peaks analyzed, the 1304 cm−1 peak increased while the 1265 cm−1 peak decreased throughout gestation (dashed lines in Fig. 3A,B). The 1304 cm−1 to 1265 cm−1 Raman peak ratio tentatively assigned to lipid/protein change42, 43 increased starting at day 12 in both mouse models, however, the rate of change was higher and reached a larger ratio in the WT compared to the Cox-1 KO (Fig. 3C) (p < 0.05). Furthermore, a sharp decrease was observed in the WT on day 19 of pregnancy (p < 0.05), but this decrease did not occur in the Cox-1 KO until day 20 (Fig. 3C). The trends seen in other Raman peaks at 1003 cm−1 (phenylanaline42), 1440 cm−1 (lipids43), and 1657 cm−1 (proteins42) are displayed in Supplementary Fig. S1. To test the generalizability of the Raman spectral changes measured over pregnancy, as well as provide curve analysis and interpolation between measured points, a generalized linear model was developed (Fig. 3D). The 1304/1265 cm−1 peak ratio model showed similar features to the data presented in Fig. 3C, and revealed highly significant changes as a function of gestational age (p < 0.0005) and mouse model (p < 0.0005).

Besides 1304/1265 cm−1, multiple peak ratios displayed significantly different trajectories over the course of pregnancy between WT and Cox-1 KO mice. Figure 4A shows the trajectory of the 1265 cm−1/1440 cm−1 ratio which gradually decreased until day 12 in both mouse models. The WT showed a steeper decrease from day 12 to day 18, but then sharply increased on day 19. The Cox-1 KO did not decrease as steeply and not until day 15 before sharply increasing on day 20. The three phases of spectral change may be analogous to the softening, ripening and dilation phases3 in WT and Cox-1 mice but with a delay in the ripening to dilation transition in the Cox-1 KO mice. The 1265/1440 cm−1 ratio model showed significant changes over the course of pregnancy (p < 0.0005) and as a function of mouse model ((p < 0.0005), as well as in the interaction between gestation and mouse model (p < 0.05) (Fig. 4B).

A non-negative least squares (NNLS) analysis was performed to understand the biochemical basis of the in vivo Raman spectra. Pure spectra were collected from collagen I, water, and adipose tissue which revealed characteristic fingerprints, demonstrating molecular specificity (Supplementary Fig. S2). Although adipose tissue is not known to be present within the cervix, it is likely that surrounding fat pads such as the inguinal, perigonadal, and lower pelvic fat pads were detected in some of the Raman spectra51, and as such adipose was incorporated into the NNLS model. A representative cervical tissue spectrum (black) was fit using the NNLS model (red) developed using the pure component spectra, and then overlaid with the residual (blue) (Supplementary Fig. S2). The residual was small and fluctuated above and below zero. Furthermore, the least squares fit was decomposed such that the contribution from each component was easily seen (Supplementary Fig. S2). The contribution of collagen in Raman signals decreased over the course of pregnancy starting on day 12 in WT and Cox-1 KO mice. WT levels steadily declined until day 18 and then spiked on day 19, but Cox-1 KO levels plateaued at day 15 and increased on day 19 and 20 (Fig. 4C). The collagen coefficient was also analyzed using the developed generalized linear model (Fig. 4D), and revealed significant changes over gestation (p < 0.0001), but no significant differences were reported between mouse models. To verify this result without the influence of adipose tissue, the cervix was excised from non-gravid and day 19 WT mice and Raman spectra were obtained. The spectra were fit to the NNLS model which revealed that the collagen coefficient was lower on day 19 of pregnancy (Supplementary Fig. S3), similar to the in vivo results.

Wild type and Cox-1 KO ex vivo cervical biomechanical properties deviate at the end of pregnancy

After performing in vivo Raman spectroscopy, the cervices of select mice (n = 8–9 per group, per time point) were excised for paired ex vivo biomechanical testing to determine whether mechanical properties changed in response to altered tissue biochemistry with pregnancy. A defined tissue displacement protocol was followed for biomechanical testing (Fig. 5A). Representative data from a WT day 15 cervix that underwent stress-relaxation testing is shown in Fig. 5B; red circles indicate the impulse stress experienced by the tissue for each increase in displacement and provides information regarding the elastic nature of the tissue. Blue circles indicate the equilibrium stress that cervical tissues maintained after a strain, providing information on viscous properties.

Figure 5.

Figure 5

Cox-1 KO mice have less distensible cervices at term than WT. (A) Displacement protocol used for biomechanical stress relaxation tests. (B) Representative data from stress-relaxation biomechanical tests. Red circles highlight the maximum impulse stress observed for each displacement; blue circles highlight the equilibrium stress observed four minutes post displacement. (C) Average stress-relaxation recordings from WT day 19, Cox-1 KO day 19, and Cox-1 day 20 cervical tissues. (D) Inset of the average stress-relaxation data from the first three displacements. (E,F) Average exponential fits to the impulse stiffness and equilibrium stiffness results from WT day 19, Cox-1 KO day 19, and Cox-1 KO day 20 cervical tissues, *p < 0.05 compared to day 19 WT. (G) Unloaded dilation of ex vivo cervical tissues from WT and Cox-1 KO mice across gestation (n = 8–10 per group, per time point). (H) Total dilation of ex vivo cervical tissues prior to tissue failure.

Average raw data generated from WT day 19, Cox-1 KO day 19, and Cox-1 day 20 mice segregated into distinct groups (Fig. 5C,D). Over the first three displacements performed (Fig. 5D), Cox-1 day 19 tissues experienced the greatest amount of stress per millimeter of displacement, followed by the Cox-1 day 20 tissues, and then WT day 19 tissues, which exhibited a smaller degree of stress, particularly at the first two displacements.

The impulse and equilibrium stress were modeled using an exponential curve described by Timmons et al.21 to compare the stiffness of the cervical tissues in WT and Cox-1 KO mice. The stresses were significantly greater in the gestation day 19 Cox-1 KO tissues compared to day 19 WT and day 20 Cox-1 KO (Fig. 5E,F). The A and B coefficients were significantly higher in Cox-1 KO day 19 tissues compared to WT day 19 and Cox-1 KO day 20 (Table 1, p < 0.05), indicating that the Cox-1 KO tissues experienced greater stress at small and large displacements, respectively. Taken together, these data (Fig. 5A–F) indicate that the Cox-1 KO cervix is more rigid at term, but becomes more like the compliant WT cervix after one additional day of gestation.

Initial dilation of the cervical os measured in excised, unloaded tissues was significantly different (p < 0.05) between time-matched WT and Cox-1 KO mice on gestation day 15 and 19, as well as between day 18 WT and day 19 Cox-1 KO (Fig. 5G). However, day 19 WT compared to day 20 Cox-1 KO was not significantly different, indicating catch-up dilatability of the post-mature Cox-1 KO cervix under baseline conditions. Total cervical dilation (initial dilation + displacement at failure during stress-relaxation testing) was measured across gestation (Fig. 5H). On day 19 of pregnancy, the WT cervix was able to dilate to a greater extent than Cox-1 KO before tissue failure occurred (p < 0.05). No difference was observed between the day 19 WT and day 20 Cox-1 KO cervices, suggesting eventual catch-up of KO tissues as the parturition delay continued.

In vivo Raman spectra correlate with ex vivo biomechanical measures

Multiple Spearman correlations were computed between Raman spectral features and mechanical measures (Fig. 6). The black box highlights correlations between Raman spectra and biomechanical properties of the cervix where strong positive correlations (bright red) and strong negative correlations (bright blue) were observed. Many of these comparisons were statistically significant, with the highest correlations coming from the Raman spectral collagen coefficient (p < 0.005 for all biomechanical comparisons), followed by the 1304/1265 cm−1 lipid/protein ratio (p < 0.05 for all biomechanical comparisons).

Figure 6.

Figure 6

In vivo Raman data correlate with ex vivo biomechanical properties. Spearman correlation matrix containing four Raman peak ratios and a non-negative least squares component representative of collagen signatures for comparison to the impulse stiffness, impulse x intercept, equilibrium stiffness, equilibrium x intercept, initial opening, total dilation, and maximum stress measures obtained during biomechanical testing.

Cervix progesterone levels remain elevated in Cox-1 KO mice at the end of pregnancy

Progesterone levels are elevated during pregnancy to maintain a quiescent state in mice. Cervical tissue progesterone levels were measured using radioimmunoassay detection in WT mice on gestation day 17 to determine progesterone levels prior to the onset of labor, on gestation day 19 to measure pre-parturition levels, and on day 19.5 to measure levels at the time of active labor. Similarly, Cox-1 KO cervical tissues were measured on gestation days 17, 19, and 19.5, as well as gestation day 20 due to delayed parturition (Fig. 7A). As expected, gestation day 17 progesterone values were the highest in both WT and Cox-1 KO pregnant mice since luteolysis had not yet occurred. On gestation day 19, progesterone levels declined in both WT and Cox-1 KO mice compared to day 17 (p < 0.001) although Cox-1 KO levels remained significantly elevated compared to WT (p < 0.005). On gestation day 19.5, progesterone levels were significantly lower (p < 0.05) in the WT group compared to time-matched Cox-1 KO mice. While Cox-1 KO mice still had higher mean progesterone levels on gestation day 20 compared to WT mice on gestation day 19.5, the difference was not statistically significant (p = 0.13).

Figure 7.

Figure 7

Ex vivo biochemical assays of cervix composition show delayed remodeling and Cox-1 KO mice. (A) Cervix progesterone levels. (B) Water content. (C) Total collagen. (D) Collagen concentration (μg/mg wet weight). Plotted as mean ± SEM, *p < 0.05 compared to day 19 WT.

Tissue hydration and collagen content significantly differ at term gestation

In order to validate the results obtained from in vivo Raman spectroscopy, we performed ex vivo biochemical assays to measure tissue hydration and collagen content in cervix samples from WT and Cox-1 KO mice. Gestation day 19 WT mice had significantly greater water content than Cox-1 KO mice on day 19 (p < 0.05) but not day 20 as indicated by these assays (Fig. 7B). An established collagen assay based on hydroxyproline content was used to determine the total collagen content (micrograms of collagen per tissue) (Fig. 7C). Total collagen slowly increased from day 15 within both WT and Cox-1 KO mice. However, significantly higher (p < 0.01) levels of collagen were detected in WT mice on day 19, which was eventually achieved in the Cox-1 KO mice on day 20 of gestation. No significant differences were observed between WT and Cox-1 KO cervical tissues in collagen concentration (Fig. 7D) for any time points examined.

Discussion

Prostaglandins are key regulators of multiple aspects of female reproduction, including uterine contractility, and cervical ripening in inflammation-induced preterm birth21, 52, 53. Impaired luteolysis and prevention of the expected progesterone decline in Cox-1 KO mice is currently considered the mechanism for delayed parturition in these mice29 and similar models of prolonged gestation15, 29, 5458. Despite speculation of suppressed uterine contractility of Cox-1 KO mice, we observed unhindered uterine contractility despite a 2–3 day delay in delivery of offspring, indicating that uterine contractility is not the basis for delayed parturition and suggests that impaired cervical remodeling may be responsible for preventing normal birth timing30. We used Raman spectroscopy to show for the first time that parturition-related changes in biochemical composition of the cervix are delayed in Cox-1 mice. This optical technique correlates to biomechanical measures of cervical rigidity and can be used to non-invasively stage maturation of the cervix over the course of pregnancy and in the pre-parturition period leading up to birth.

Although prostaglandins are widely regarded as essential molecules for cervical ripening, our data showing restricted Cox expression in the pregnant mouse cervix corroborate recent unexpected findings by Timmons et al.21 where low levels of Cox-1 and Cox-2 expression and low cervical prostaglandin levels were noted during normal pregnancy. Cervix prostaglandin levels were increased in the immediate post-partum period, likely related to heightened Cox expression or via prostaglandin synthesis in nearby uterine tissues (Fig. 1), which then bind and activate cervix prostaglandin receptors59. While upregulation of Cox-2 can partially compensate for the absence of Cox-1 in the uterus60, we previously showed that prostaglandin levels were at the lower limits of detection in Cox-1 KO uteri12. Interestingly, our present study showed that deletion of Cox-1 did not impair uterine contractions (Fig. 1C,D). It was previously thought that Cox-1-derived prostaglandins directly stimulate myometrial contractility or that PGF2α acts on the corpus luteum, leading to subsequent luteolysis, progesterone fall, and uterine activation for labor61. The compensatory mechanisms enabling normal uterine contractions in Cox-1 KO mice are not yet fully understood, but support an impaired cervical remodeling hypothesis that was tested in the current study.

In vivo Raman spectroscopy revealed significant changes in the biochemical makeup of the cervix over the course of pregnancy. Highly significant differences observed in Cox-1 KO compared to WT cervices near term provide the first evidence supporting impaired cervical remodeling as a novel factor responsible for the parturition delay in Cox-1 KO mice. In particular, Cox-1 KO mice show a gradual increase in the 1304 cm−1/1265 cm−1 peak ratio compared to a non-linear increase in the WT peak ratio over pregnancy, with a sharp decrease at term in WT and one day after term in Cox-1 KO (Fig. 3). The peak at 1265 cm−1 decreased linearly over pregnancy, which is assigned to the Amide III vibration (C-N stretching and N-H in-plane bending from peptide backbone) present in various structural proteins, as well as in-plane cis double bond =C-H bending from lipid molecules such as adipose tissue and phospholipids43, 62. The 1304 cm−1 peak is assigned to scissoring and twisting vibrations of CH3 groups in lipids43, but also has overlap with spectral bands in actin, elastin, and nucleic acids42, 45, 63, 64. Thus, this ratio is tentatively assigned as a lipid-to-protein ratio and may be indicative of an increase in collagen disorganization relative to cellular content in the softening and ripening stages of pregnancy.

A reduced rate of change in the 1265 cm−1/1440 cm−1 ratio was observed in the ripening phase in Cox-1 KO mice compared to WT (Fig. 4A,B). The 1440 cm−1 peak is characteristic of CH2/CH3 scissoring in lipids43. Collagen and other extracellular matrix proteins break down over the course of pregnancy4 and are likely responsible for the observed decrease in this ratio as pregnancy advanced. Significant changes over the course of pregnancy were also noted in the NNLS collagen coefficient (Fig. 4C,D), where both WT and Cox-1 KO levels significantly decreased starting on day 12 of pregnancy. The collagen concentration is known to decrease during pregnancy8, 65, which aligns with results from both the in vivo and ex vivo Raman spectra. In contrast to the peak ratios, the Cox-1 KO collagen coefficient did not sharply rise at term, nor were significant differences found between WT and Cox-1 KO mice at term, indicating that sharp changes observed prior to parturition in Figs 3 and 4A,B may not be centered on collagen. It should be noted that although the pure components measured for the developed NNLS model account for a large amount of the variability observed in the collected data set, not all of the potential biochemical contributors to the measured Raman signal are incorporated. Additional cervical components include but are not limited to actin, elastin, glycosaminglycans, and nucleic acids3, 66, 67, and likely contribute to the sharp changes observed prior to delivery in both WT and Cox-1 KO mice in the Raman peak ratios (Figs 3C and 4A), and WT mice in the NNLS analysis (Fig. 4C).

Differences observed in Raman spectra were supported by ex vivo biomechanical tests (Fig. 5), which showed that the cervix of day 19 Cox-1 KO mice had significantly higher impulse stiffness and equilibrium stiffness compared to day 19 WT. Possible explanations for the impulse stiffness include higher levels of collagen crosslinks in the Cox-1 KO tissue at term4, whereas less dispersion of collagen fibers and less hydrated cervical stroma could prevent viscous relaxation resulting in higher equilibrium stiffness68, 69. Furthermore, Cox-1 KO day 19 tissues were less compliant in both unloaded states (initial dilation) as well as the maximum stretch-induced dilation state (total dilation or ultimate cervical compliance) compared to day 19 WT cervices. The latter two measures offer complementary information. Initial dilation reflects tissue compliance without application of any external force (other than gravity) similar to cervical dilation assessment in non-laboring women. For example, pregnant women with cervical dilation <3 cm require additional force to produce dilation sufficient for parturition compared to women dilated to 8 cm (maximum of 10 cm for complete dilation), even if both patients have an equally softened cervix. Although the in vivo cervix is always under load70, our experiments isolated the cervix from surrounding tissue forces and pressure from the fetus to provide information on inherent cervical distensibility. Total dilation, which yields the maximum stretch cervical tissue can withstand prior to tissue failure, is similar to the requirement for human cervical dilation to 10 cm. Regardless of cervical diameter at the onset of labor, delivery will not be successful until complete dilation is achieved, and is therefore an absolute, not relative requirement for parturition. Together, this information confirms that normal transition to the cervical dilation phase was delayed in Cox-1 KO mice, resulting in reduced capacity to reach the final dilation needed to successfully deliver at term.

Successful passage of a fetus depends on achievement of cervical remodeling and complete cervical dilation. Currently, physical and biomechanical assessments are the most commonly used measures of cervical remodeling. Here, we showed that Raman peak ratios and changes in biochemical composition of the cervix correlate with biomechanical properties and physical changes in cervical stiffness and compliance (Fig. 6). The highest correlation observed was between the Raman collagen coefficient and the initial dilation. Fibrillar collagens largely govern the mechanical properties of cervical tissue, supporting the feasibility of using Raman measurements to interrogate cervical maturation during the quiescent phase of pregnancy and with impending parturition. Biochemistry is known to play a key role in mechanical properties68, 69, 71; however, biochemistry alone cannot fully capture the structure and packing of all molecules that contribute to biomechanical properties. As such, pairing Raman spectroscopy with another structurally-focused modality could greatly improve the determination of mechanical properties in vivo. Engineering models of cervical biomechanics72 and biochemical inputs determined via Raman spectroscopy could be valuable additions when applying such models towards non-invasive assessment of cervical tissue.

Ex vivo biochemical assays similarly revealed differences between WT and Cox-1 KO cervical tissues at the end of pregnancy. Significantly higher progesterone levels were noted in Cox-1 KO mice on day 19 compared to WT, however unlike previous reports29, progesterone levels clearly fell in both groups, albeit not to the same extent. This suggests the possibility of a progesterone-mediated delay in cervical dilation, similar to two other mouse models of delayed parturition in which systemic progesterone levels remain elevated: Steroid 5a-reductase type-1 knockout mice and Tg/Tg mice with an insertion in chromosome 654, 57. Water content rose significantly on the final day of pregnancy in WT mice, which was not observed in the Cox-1 KO day 19 tissues. Cervical hydration typically increases over the course of pregnancy, particularly in the ripening/dilation phase68. Similarly, total collagen per cervical tissue rose significantly on the final day of gestation in WT mice compared to Cox-1 KO, however collagen levels in the day 20 Cox-1 KO cervix eventually caught up to day 19 WT levels (Fig. 7C).

One limitation of this study is the contribution of adipose tissue to the in vivo Raman spectra collected from the cervix. Multiple steps were taken to minimize the influence of adipose tissue whilst maintaining information from the cervix, including an automated system for removing spectra that had high adipose content (spectra with the 1440 cm−1 peak >1800 counts). In addition, the generalized linear model incorporates the 1440 cm−1 signal intensity as a model variable so that the non-adipose content could be independently analyzed. This allowed for prediction of how the spectra would change over gestation given a constant adipose contribution. This method can be used for other applications where an additional signal is interfering with spectra from a desired location, including interference from adipose tissue and bone. Beyond quantitative data exclusion (by pre-determined criteria) and post-processing analysis, a variety of hardware solutions could be used to minimize the variability introduced by adipose. Use of a custom Raman fiber optic probe that is focused to superficial tissue depths could reduce contribution from deep adipose layers73. Furthermore, a spatially offset probe design could provide depth-resolved information with minimal signal from adipose tissue reaching the low source-detector distance fibers74. Finally, use of a lower wavelength such as 680 nm or 532 nm would inherently limit the penetration depth of the laser light, and therefore reduce contribution from adipose tissue located behind the cervix, however visible excitation sources are likely to lead to greater tissue heating and autofluorescence signal generation75.

In summary, we identified delayed cervical remodeling in pregnant Cox-1 KO mice as an underlying mechanism for prolonged gestation. Specifically, in vivo Raman spectroscopy detected significant differences between WT and Cox-1 KO cervical tissues during pregnancy, particularly in peaks representative of proteins and lipids. Spectral analysis correlated with biochemical changes, biomechanical testing, and reduced cervical dilation in Cox-1 KO mice at term. This study underscores the importance of studying the cervix in the context of abnormal parturition, which remains a relatively under-investigated organ. Difficulty obtaining molecular information from cervical tissue without compromising pregnancy has driven new innovation, including in vivo Raman spectroscopy. As a non-invasive, real-time technique that can be performed longitudinally, biochemical differences that occur throughout pregnancy can be detected without tissue injury or potential harm. Our study demonstrates that this technique, which has been used in a variety of human studies76, has clear potential for direct clinical translation.

Methods

Animals

All experiments involving animals were conducted in accordance with the regulations described in the NIH Guide for the Care and Use of Laboratory Animals, using protocols approved by Vanderbilt University Medical Center’s Institutional Animal Care and Use Committee (IACUC). Two groups of mice were investigated, CD-1 wild type (Jackson Laboratory) and Cox-1 null28. The Cox-1 null mouse was outbred to the CD-1 strain for 10 generations12. Animals were housed under a 12 hour dark-light cycle. Timed matings were conducted in the evenings and the presence of a post-copulatory plug the following morning defined gestation day 1. Wild type mice in this colony typically deliver on the evening of day 19 (designated d19.5). Six time points during pregnancy were investigated for each mouse genotype; WT mice were measured on days 4, 12, 15, 18, 19, and non-gravid, whereas Cox-1 KO mice were measured on days 4, 12, 15, 19, 20, and non-gravid. Non-gravid mice were measured in the diestrus phase of the estrous cycle as determined by vaginal lavage.

In situ hybridization

Eleven micron thin frozen uterine sections were obtained from WT and Cox-1 KO mice and mounted on the same glass slides and in situ hybridization was performed as previously described77.

Ex vivo myometrial contractility

Uterine myometrial strips were collected post-mortem, and used in an ex vivo isometric contractility assay as previously described78.

Raman spectroscopy

A portable, fiber optic probe-based Raman spectroscopy system was used (Fig. 2E) for all Raman measurements acquired. The system consisted of an imaging spectrograph (Holospec f/1.8i, Kaiser Optical Systems, Ann Arbor, MI) coupled to a thermoelectrically cooled CCD camera (PIXIS: 256BR, Princeton Instruments, Princeton, NJ). A 785 nm diode laser (Innovative Photonic Solutions, Monmouth Junction, NJ) delivered 80 mW of power through a custom made fiber optic probe (Fig. 2D) (EmVision, Loxahatchee, FL) to the cervix.

The system was wavelength calibrated using a neon-argon lamp, and naphthalene and acetaminophen standards were used to determine the exact excitation wavelength for subsequent Raman shift calculations. The system was corrected for spectral response using a tungsten lamp that was calibrated by the National Institute of Standards and Technology. Spectra were smoothed using a Savitzky-Golay filter, background subtracted, and fluorescence subtracted using a modified polynomial fit method previously described79.

During measurements, all room lights were turned off. For in vivo experiments, animals were anesthetized using isoflurane, and the vaginal cavity and cervix were rinsed gently using saline. A small speculum tube was inserted to improve visualization of the mouse cervix and ensure contact of the fiber probe with the proper tissues during measurements (Fig. 2A–C). A range of 5–10 spectra were taken at multiple locations around the ectocervix of each mouse with an integration time of 3 seconds per measurement. For ex vivo experiments, the cervix was excised and immediately measured using an integration time of 10 seconds.

Raman data analysis

Processed, non-normalized Raman spectra were used for data analysis. The signal to noise ratio (SNR) and adipose tissue signal from each Raman spectrum was calculated, and spectra with low signal (less than 100 counts at the 1440 cm−1 peak) as well as spectra with high adipose content (greater than 1800 counts at the 1440 cm−1 peak) were removed from analysis. Raman spectra were averaged by each mouse for display in Figs 2 and 3. Ratios from Raman peaks were calculated prior to averaging, and the results were subsequently averaged for each mouse. Peak ratios sensitive to ECM, lipids, and nucleic acids were plotted using the mean and standard error for each mouse model and gestation. Ratios were used as a way to normalize and make comparisons across many data sets that have varying levels of signal intensity and SNR. Student t-tests were performed to determine statistical significance (α = 0.05) between WT and Cox-1 KO mice at each gestation measured.

Raman spectra were modeled using generalized linear models in the R software, using the RMS package. The rate of change of various Raman peak ratios and NNLS coefficients over gestation were modeled and the WT and Cox-1 KO curves were compared. In this analysis, the Raman peak ratio or NNLS coefficient of interest was the dependent variable, whereas the gestation time and mouse model were independent variables. To account for signal intensity fluctuations, the spectral intensity (measured as the intensity of the 1440 cm−1 peak) was added as another independent variable which acts as a baseline offset. The time variable was modeled as a restricted cubic spline with three nodes to allow for non-linear behavior with respect to time. The last time point for each model (WT = 19, Cox-1 KO = 20) was assigned an indicator variable that allowed for the capture of significant changes at the end of pregnancy. The mouse model was set as a factor variable. To account for heteroscedasticity, the robust covariance function created in the rms package (‘robcov’) was used to adjust the standard errors. Finally, to evaluate interactions between the gestation time and mouse model, an ANOVA was performed on the generated curves from the developed regression model.

Non-negative least squares analysis was performed to determine the contributions of 3 different biochemical components as a function of gestation and mouse model8082. This analysis follows the equation Y = β*X + ε, where the design matrix X was filled with pure biochemical spectra (collagen type I (Sigma), adipose tissue (collected from mouse abdomen post-mortem), and water), and the tissue spectrum being analyzed in Y. The optimum coefficients β that minimize the error ε were determined for each spectrum. For this analysis, NNLS regression was performed (MATLAB) such that components could not have a negative contribution on a spectral fit. For this study, the term “residual’ was defined as the difference between the “observed spectrum” and the “fitted spectrum”. A negative residual meant that in certain regions of the spectrum, the “fitted spectrum” was of greater intensity than the “observed spectrum.” None of the NNLS coefficients were calculated to be negative. The residuals per spectrum were summed and all spectra with a summed residual higher than 0.3 were removed from further analysis. The average coefficients for each biochemical component were calculated as a function of mouse model and gestation. Spearman correlations were performed on four Raman peak ratios and the collagen NNLS coefficient which were compared with biomechanical measures.

Ex vivo biomechanical testing

Cervical tissue was excised post-mortem by cutting perpendicularly across the uterocervical junction where the uterine horns converge into the cervical canal. All vaginal tissue was removed and the dimensions of the cervical tissue were measured. The freshly excised cervical tissue was immediately placed in oxygenated Krebs Bicarbonate buffer at 37 °C for 10 minutes to equilibrate. Next, the tissue underwent stress-relaxation testing using a Radnoti Organ Bath System. This method allowed assessment of the viscoelastic behavior of each cervical tissue. The system was calibrated by recording force (measured in volts) with no added weight and with a 100 gram test weight, and the measured voltage was converted to force (mass x gravity). The tissue was then mounted on two stainless steel triangular hooks and attached to a force transducer with a mechanical drive. The hooks were slowly pulled apart until tension in the tissue was measured, after which the separation between the hooks was reduced to determine the “initial dilation” of the cervical tissue without strain-induced stress. This baseline distance (initial dilation) was recorded for each specimen, and then the stress-relaxation testing protocol was initiated as follows. The cervical tissue remained in an unloaded state for four minutes, and then experienced a strain of 0.1 mm/s for a total of ten seconds (one mm displacement), after which the strain was held constant for four minutes. This protocol was repeated until tissue failure, defined as the displacement at which sudden loss of stress is experienced by the tissue under tensile loading83, as shown in Fig. 5A. This process was controlled using stepper motors (Applied Motion Products) that were programmed with an Arduino Uno board. Recorded data was converted into stress based on the cross-sectional area of the tissues. Total dilation was calculated as the initial dilation plus displacement during biomechanical testing prior to tissue failure. Equilibrium stiffness was calculated for each tissue by plotting the average stress from the last 30 seconds of each stress cycle and generating a curve. The slope of the linear region of each curve was calculated as a simple measure of stiffness, as well as a model fit to the following exponential model described by Timmons et al.21:

Stress=(A/B)[exp(cervicalopeningB)1],

where the parameters A and B measure the stiffness at small and large displacements, respectively. The impulse stiffness was calculated for each tissue by plotting the maximum stress achieved from each stress cycle and generating a curve, which was similarly evaluated by taking the slope in the linear region, and a fit to the exponential model. Statistical analysis was performed on initial dilation, total dilation, equilibrium stiffness A and B coefficients, and impulse stiffness A and B coefficients using t-tests (*indicates p < 0.05).

Ex vivo biochemical assays

For all ex vivo biochemical assays, cervical tissues were excised post-mortem, immediately flash frozen with Super Friendly FREEZE’IT (Fisher Scientific) and then placed in −80 C.

Progesterone concentrations were measured by the Endocrine Technologies Support Core (ETSC) at the Oregon National Primate Research Center (ONPRC, Beaverton, OR) using extraction-radioimmunoassay (RIA)84. Tissue samples were weighed and homogenized in 1 ml PBS, then extracted with 6 ml diethyl ether, dried under forced air stream and re-dissolved in assay buffer (0.1% gel-PBS). Progesterone values were corrected for extraction losses determined by radioactive trace recovery performed simultaneously with sample extraction, which ranged between 95.3–96.8% (n = 3). The assay range for the P4-extraction RIA was 5–750 pg/tube. The intra-assay variation for the assays ranged from 5.8–8.9% and inter-assay variation was 7.3%. Overall inter-assay variation for extraction-RIAs in the ETSC is less than 15%.

For cervical hydration and collagen content assays, tissues were weighed, and then lyophilized overnight. After freeze-drying, the tissues were weighed again. Based on these measurements, water content was determined as (wet weight/(wet weight + dry weight)). Next, a standard collagen extraction procedure was performed as previously described8. To quantify collagen content, a hydroxyproline assay was performed per manufacturer’s instructions (BioVision).

Data Availability

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.

Electronic supplementary material

Supplementary Figures (138.3KB, pdf)

Acknowledgements

The authors wish to thank Dr. Kelsey Mayo for the illustration of the cervix in Fig. 2, and the Endocrine Technologies Support Core (ETSC) at the Oregon National Primate Research Center (ONPRC) supported by NIH Grant P51 OD011092 awarded to ONPRC. We thank Stanley Poole, Becca Williams, Woodi Woodland, and Kevin Qin for help executing experiments and data processing. We acknowledge our funding sources including an NSF Graduate Research Fellowship awarded to CO, and NIH R01 HD081121 (J.R. and A.MJ).

Author Contributions

C.O., J.H. and N.B, conducted mouse experiments. C.O., I.P., and J.S. conducted statistical analysis. C.O., J.H., B.P., J.R., and A.MJ. contributed to data interpretation and study design.

Competing Interests

The authors declare that they have no competing interests.

Footnotes

Jeff Reese and Anita Mahadevan-Jansen contributed equally to this work.

Electronic supplementary material

Supplementary information accompanies this paper at doi:10.1038/s41598-017-07047-5

Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Romero R, Dey SK, Fisher SJ. Preterm Labor: One Syndrome, Many Causes. Science (New York, N.Y) 2014;345:760–765. doi: 10.1126/science.1251816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Feltovich, H., Hall, T. & Berghella, V. Beyond cervical length: emerging technologies for assessing the pregnant cervix. Am J of Obstet and Gynecol07 (2012). [DOI] [PMC free article] [PubMed]
  • 3.Word RA, Li XH, Hnat M, Carrick K. Dynamics of cervical remodeling during pregnancy and parturition: mechanisms and current concepts. Semin Reprod Med. 2007;25:69–79. doi: 10.1055/s-2006-956777. [DOI] [PubMed] [Google Scholar]
  • 4.Yoshida K, et al. Quantitative Evaluation of Collagen Crosslinks and Corresponding Tensile Mechanical Properties in Mouse Cervical Tissue during Normal Pregnancy. PloS one. 2014;9:e112391. doi: 10.1371/journal.pone.0112391. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Akgul Y, Holt R, Mummert M, Word A, Mahendroo M. Dynamic changes in cervical glycosaminoglycan composition during normal pregnancy and preterm birth. Endocrinology. 2012;153:3493–3503. doi: 10.1210/en.2011-1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Anderson J, Brown N, Mahendroo MS, Reese J. Utilization of Different Aquaporin Water Channels in the Mouse Cervix during Pregnancy and Parturition and in Models of Preterm and Delayed Cervical Ripening. Endocrinology. 2006;147:130–140. doi: 10.1210/en.2005-0896. [DOI] [PubMed] [Google Scholar]
  • 7.Straach KJ, Shelton JM, Richardson JA, Hascall VC, Mahendroo MS. Regulation of hyaluronan expression during cervical ripening. Glycobiology. 2005;15:55–65. doi: 10.1093/glycob/cwh137. [DOI] [PubMed] [Google Scholar]
  • 8.Read CP, Word RA, Ruscheinsky MA, Timmons BC, Mahendroo MS. Cervical remodeling during pregnancy and parturition: molecular characterization of the softening phase in mice. Reproduction. 2007;134:327–340. doi: 10.1530/REP-07-0032. [DOI] [PubMed] [Google Scholar]
  • 9.Feltovich H, et al. Effects of selective and nonselective PGE2 receptor agonists on cervical tensile strength and collagen organization and microstructure in the pregnant rat at term. Am J Obstet Gynecol. 2005;192:753–760. doi: 10.1016/j.ajog.2004.12.054. [DOI] [PubMed] [Google Scholar]
  • 10.Challis JR, et al. Prostaglandins and mechanisms of preterm birth. Reproduction. 2002;124:1–17. doi: 10.1530/rep.0.1240001. [DOI] [PubMed] [Google Scholar]
  • 11.Timmons B, Akins M, Mahendroo M. Cervical remodeling during pregnancy and parturition. Trends Endocrinol Metab. 2010;21:353–361. doi: 10.1016/j.tem.2010.01.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Reese J, et al. Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proc. Natl. Acad. Sci. USA. 2000;97:9759–9764. doi: 10.1073/pnas.97.17.9759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Reese J, et al. Comparative analysis of pharmacologic and/or genetic disruption of cyclooxygenase-1 and cyclooxygenase-2 function in female reproduction in mice. Endocrinology. 2001;142:3198–3206. doi: 10.1210/endo.142.7.8307. [DOI] [PubMed] [Google Scholar]
  • 14.Roizen JD, Asada M, Tong M, Tai HH, Muglia LJ. Preterm birth without progesterone withdrawal in 15-hydroxyprostaglandin dehydrogenase hypomorphic mice. Mol Endocrinol. 2008;22:105–112. doi: 10.1210/me.2007-0178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Sugimoto Y, et al. Failure of parturition in mice lacking the prostaglandin F receptor. Science. 1997;277:681–683. doi: 10.1126/science.277.5326.681. [DOI] [PubMed] [Google Scholar]
  • 16.Yellon SM, Ebner CA, Sugimoto Y. Parturition and recruitment of macrophages in cervix of mice lacking the prostaglandin F receptor. Biol Reprod. 2008;78:438–444. doi: 10.1095/biolreprod.107.063404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Cabrol D, et al. Prostaglandin E2-induced changes in the distribution of glycosaminoglycans in the isolated rat uterine cervix. Eur. J. Obstet. Gynecol. Reprod. Biol. 1987;26:359–365. doi: 10.1016/0028-2243(87)90135-3. [DOI] [PubMed] [Google Scholar]
  • 18.Uldbjerg N, Ekman G, Malmstrom A, Ulmsten U, Wingerup L. Biochemical changes in human cervical connective tissue after local application of prostaglandin E2. Gynecol. Obstet. Invest. 1983;15:291–299. doi: 10.1159/000299423. [DOI] [PubMed] [Google Scholar]
  • 19.Rath W, et al. Biochemical changes in human cervical connective tissue after intracervical application of prostaglandin E2. Prostaglandins. 1993;45:375–384. doi: 10.1016/0090-6980(93)90114-M. [DOI] [PubMed] [Google Scholar]
  • 20.Buhimschi IA, Dussably L, Buhimschi CS, Ahmed A, Weiner CP. Physical and biomechanical characteristics of rat cervical ripening are not consistent with increased collagenase activity. American Journal of Obstetrics and Gynecology. 2004;191:1695–1704. doi: 10.1016/j.ajog.2004.03.080. [DOI] [PubMed] [Google Scholar]
  • 21.Timmons BC, et al. Prostaglandins are essential for cervical ripening in LPS-mediated preterm birth but not term or antiprogestin-driven preterm ripening. Endocrinology. 2014;155:287–298. doi: 10.1210/en.2013-1304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Platz-Christensen JJ, Pernevi P, Bokstrom H, Wiqvist N. Prostaglandin E and F2 alpha concentration in the cervical mucus and mechanism of cervical ripening. Prostaglandins. 1997;53:253–261. doi: 10.1016/S0090-6980(97)89599-8. [DOI] [PubMed] [Google Scholar]
  • 23.Toth M, Rehnstrom J, Fuchs AR. Prostaglandins E and F in cervical mucus of pregnant women. Am. J. Perinatol. 1989;6:142–144. doi: 10.1055/s-2007-999565. [DOI] [PubMed] [Google Scholar]
  • 24.Cox SM, King MR, Casey ML, MacDonald PC. Interleukin-1 beta, -1 alpha, and -6 and prostaglandins in vaginal/cervical fluids of pregnant women before and during labor. J Clin Endocrinol Metab. 1993;77:805–815. doi: 10.1210/jcem.77.3.8370702. [DOI] [PubMed] [Google Scholar]
  • 25.Kavanagh, J., Kelly, A. J. & Thomas, J. Sexual intercourse for cervical ripening and induction of labour. The Cochrane database of systematic reviews, Cd003093 (2001). [DOI] [PMC free article] [PubMed]
  • 26.Elovitz M, Mrinalini C. Animal models of preterm birth. Trends Endocrinol Metab. 2004;15:479–487. doi: 10.1016/j.tem.2004.10.009. [DOI] [PubMed] [Google Scholar]
  • 27.Mahendroo M. Cervical remodeling in term and preterm birth: insights from an animal model. Reproduction. 2012;143:429–438. doi: 10.1530/REP-11-0466. [DOI] [PubMed] [Google Scholar]
  • 28.Langenbach R, et al. Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration. Cell. 1995;83:483–492. doi: 10.1016/0092-8674(95)90126-4. [DOI] [PubMed] [Google Scholar]
  • 29.Gross GA, et al. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc. Natl. Acad. Sci. USA. 1998;95:11875–11879. doi: 10.1073/pnas.95.20.11875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Herington J, O’Brien C, Brown N, Paria BC, Reese J. Timing of Embryo Implantation and Uterine Contractility Do Not Account for Delayed Parturition in Cycloxygenase-1 Knockout Mice. Reproductive Sciences. 2014;21:143A–143A. [Google Scholar]
  • 31.O’Brien CM, et al. Raman spectroscopy provides a noninvasive approach for determining biochemical composition of the pregnant cervix in vivo. Acta Paediatr. 2014;103:715–721. doi: 10.1111/apa.12630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hee L. Overview of the methods available for biomechanical testing of the uterine cervix in vivo. Acta Obstet Gynecol Scand. 2014;93:1219–1237. doi: 10.1111/aogs.12483. [DOI] [PubMed] [Google Scholar]
  • 33.Lucovnik M, Kuon RJ, Garfield RE. Assessment of Parturition with Cervical Light-Induced Fluorescence and Uterine Electromyography. Computational and Mathematical Methods in Medicine. 2013;2013:6. doi: 10.1155/2013/165913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Maul H, Saade G, Garfield RE. Prediction of term and preterm parturition and treatment monitoring by measurement of cervical cross-linked collagen using light-induced fluorescence. Acta Obstetricia et Gynecologica Scandinavica. 2005;84:534–536. doi: 10.1111/j.0001-6349.2005.00806.x. [DOI] [PubMed] [Google Scholar]
  • 35.Baños A, et al. Frequency domain near-infrared spectroscopy of the uterine cervix during cervical ripening. Lasers in Surgery and Medicine. 2007;39:641–646. doi: 10.1002/lsm.20542. [DOI] [PubMed] [Google Scholar]
  • 36.Matzinger B, Wolf M, Banos A, Fink D, Hornung R. Optical properties, physiologic parameters and tissue composition of the human uterine cervix as a function of hormonal status. Lasers Med Sci. 2009;24:561–566. doi: 10.1007/s10103-008-0611-x. [DOI] [PubMed] [Google Scholar]
  • 37.Hornung R, et al. Frequency-domain near-infrared spectroscopy of the uterine cervix during regular pregnancies. Lasers in medical science. 2011;26:205–212. doi: 10.1007/s10103-010-0832-7. [DOI] [PubMed] [Google Scholar]
  • 38.Reusch, L., Feltovich, H. & Carlson, L. Nonlinear optical microscopy and ultrasound imaging of human cervical structure. J Biomed Opt3 (2013). [DOI] [PMC free article] [PubMed]
  • 39.Zhang Y, et al. A compact fiber-optic SHG scanning endomicroscope and its application to visualize cervical remodeling during pregnancy. Proceedings of the National Academy of Sciences. 2012;109:12878–12883. doi: 10.1073/pnas.1121495109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Akins ML, Luby-Phelps K, Mahendroo M. Second harmonic generation imaging as a potential tool for staging pregnancy and predicting preterm birth. J Biomed Opt. 2010;15:026020. doi: 10.1117/1.3381184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Yao W, et al. Collagen Fiber Orientation and Dispersion in the Upper Cervix of Non-Pregnant and Pregnant Women. PLoS One. 2016;11:e0166709. doi: 10.1371/journal.pone.0166709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Rygula A, et al. Raman spectroscopy of proteins: a review. Journal of Raman Spectroscopy. 2013;44:1061–1076. doi: 10.1002/jrs.4335. [DOI] [Google Scholar]
  • 43.Czamara K, et al. Raman spectroscopy of lipids: a review. Journal of Raman Spectroscopy. 2015;46:4–20. doi: 10.1002/jrs.4607. [DOI] [Google Scholar]
  • 44.Carey DM, Korenowski GM. Measurement of the Raman spectrum of liquid water. The Journal of Chemical Physics. 1998;108:2669–2675. doi: 10.1063/1.475659. [DOI] [Google Scholar]
  • 45.Lyng FM, et al. Vibrational spectroscopy for cervical cancer pathology, from biochemical analysis to diagnostic tool. Experimental and Molecular Pathology. 2007;82:121–129. doi: 10.1016/j.yexmp.2007.01.001. [DOI] [PubMed] [Google Scholar]
  • 46.Mahadevan-Jansen A, Mitchell MF, Ramanujam N, Utzinger U, Richards-Kortum R. Development of a fiber optic probe to measure NIR Raman spectra of cervical tissue in vivo. Photochem. Photobiol. 1998;68:427–431. doi: 10.1111/j.1751-1097.1998.tb09703.x. [DOI] [PubMed] [Google Scholar]
  • 47.Kanter EM, Majumder S, Kanter GJ, Woeste EM, Mahadevan-Jansen A. Effect of hormonal variation on Raman spectra for cervical disease detection. Am J Obstet Gynecol. 2009;200:512 e511–515. doi: 10.1016/j.ajog.2008.11.024. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Duraipandian, S. et al. Effect of hormonal variation on in vivo high wavenumber Raman spectra improves cervical precancer detection. 82140A–82140A (2012).
  • 49.Duraipandian S, et al. Non-invasive analysis of hormonal variations and effect of postmenopausal Vagifem treatment on women using in vivo high wavenumber confocal Raman spectroscopy. Analyst. 2013;138:4120–4128. doi: 10.1039/c3an00526g. [DOI] [PubMed] [Google Scholar]
  • 50.Vargis E, et al. Detecting biochemical changes in the rodent cervix during pregnancy using Raman spectroscopy. Ann. Biomed. Eng. 2012;40:1814–1824. doi: 10.1007/s10439-012-0541-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Mann, A., Thompson, A., Robbins, N. & Blomkalns, A. L. Localization, Identification, and Excision of Murine Adipose Depots. e52174 (2014). [DOI] [PMC free article] [PubMed]
  • 52.Lim H, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell. 1997;91:197–208. doi: 10.1016/S0092-8674(00)80402-X. [DOI] [PubMed] [Google Scholar]
  • 53.Vannuccini S, Bocchi C, Severi FM, Challis JR, Petraglia F. Endocrinology of human parturition. Annales d’Endocrinologie. 2016;77:105–113. doi: 10.1016/j.ando.2016.04.025. [DOI] [PubMed] [Google Scholar]
  • 54.Mahendroo MS, Porter A, Russell DW, Word RA. The parturition defect in steroid 5α-reductase type 1 knockout mice is due to impaired cervical ripening. Molecular Endocrinology. 1999;13:981–992. doi: 10.1210/mend.13.6.0307. [DOI] [PubMed] [Google Scholar]
  • 55.Piekorz RP, Gingras S, Hoffmeyer A, Ihle JN, Weinstein Y. Regulation of progesterone levels during pregnancy and parturition by signal transducer and activator of transcription 5 and 20alpha-hydroxysteroid dehydrogenase. Mol Endocrinol. 2005;19:431–440. doi: 10.1210/me.2004-0302. [DOI] [PubMed] [Google Scholar]
  • 56.Zeng Z, Velarde MC, Simmen FA, Simmen RC. Delayed parturition and altered myometrial progesterone receptor isoform A expression in mice null for Kruppel-like factor 9. Biol Reprod. 2008;78:1029–1037. doi: 10.1095/biolreprod.107.065821. [DOI] [PubMed] [Google Scholar]
  • 57.Word RA, Landrum CP, Timmons BC, Young SG, Mahendroo MS. Transgene insertion on mouse chromosome 6 impairs function of the uterine cervix and causes failure of parturition. Biol Reprod. 2005;73:1046–1056. doi: 10.1095/biolreprod.105.042663. [DOI] [PubMed] [Google Scholar]
  • 58.Yu Y, et al. Differential impact of prostaglandin H synthase 1 knockdown on platelets and parturition. J Clin Invest. 2005;115:986–995. doi: 10.1172/JCI23683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Chien EK, Macgregor C. Expression and regulation of the rat prostaglandin E2 receptor type 4 (EP4) in pregnant cervical tissue. Am J Obstet Gynecol. 2003;189:1501–1510. doi: 10.1067/S0002-9378(03)00764-6. [DOI] [PubMed] [Google Scholar]
  • 60.Reese J, Brown N, Paria BC, Morrow J, Dey KS. COX-2 compensation in the uterus of COX-1 deficient mice during the pre-implantation period. Molecular and Cellular Endocrinology. 1999;150:23–31. doi: 10.1016/S0303-7207(99)00033-7. [DOI] [PubMed] [Google Scholar]
  • 61.Tsuboi K, et al. Uterine expression of prostaglandin H2 synthase in late pregnancy and during parturition in prostaglandin F receptor-deficient mice. Endocrinology. 2000;141:315–324. doi: 10.1210/endo.141.1.7236. [DOI] [PubMed] [Google Scholar]
  • 62.De Gelder J, De Gussem K, Vandenabeele P, Moens L. Reference database of Raman spectra of biological molecules. Journal of Raman Spectroscopy. 2007;38:1133–1147. doi: 10.1002/jrs.1734. [DOI] [Google Scholar]
  • 63.Silveira, L., Silveira, F. L., Bodanese, B., Zângaro, R. A. & Pacheco, M. T. T. Discriminating model for diagnosis of basal cell carcinoma and melanoma in vitro based on the Raman spectra of selected biochemicals. Journal of Biomedical Optics17, 077003-077001-077003-077011 (2012). [DOI] [PubMed]
  • 64.Mahadevan-Jansen A, Richards-Kortum RR. Raman spectroscopy for the detection of cancers and precancers. J Biomed Opt. 1996;1:31–70. doi: 10.1117/12.227815. [DOI] [PubMed] [Google Scholar]
  • 65.Rimmer DM. The effect of pregnancy on the collagen of the uterine cervix of the mouse. J. Endocrinol. 1973;57:413–418. doi: 10.1677/joe.0.0570413. [DOI] [PubMed] [Google Scholar]
  • 66.Ludmir J, Sehdev HM. Anatomy and physiology of the uterine cervix. Clinical Obstetrics and Gynecology. 2000;43:433–439. doi: 10.1097/00003081-200009000-00003. [DOI] [PubMed] [Google Scholar]
  • 67.Nott JP, Bonney EA, Pickering JD, Simpson NAB. The structure and function of the cervix during pregnancy. Translational Research in Anatomy. 2016;2:1–7. doi: 10.1016/j.tria.2016.02.001. [DOI] [Google Scholar]
  • 68.Myers KM, Socrate S, Paskaleva A, House M. A study of the anisotropy and tension/compression behavior of human cervical tissue. Journal of Biomechanical Engineering. 2010;132:021003–021003. doi: 10.1115/1.3197847. [DOI] [PubMed] [Google Scholar]
  • 69.Myers KM, Paskaleva A, House M, Socrate S. Mechanical and biochemical properties of human cervical tissue. Acta Biomaterialia. 2008;4:104–116. doi: 10.1016/j.actbio.2007.04.009. [DOI] [PubMed] [Google Scholar]
  • 70.Myers KM, et al. The mechanical role of the cervix in pregnancy. J. Biomech. 2015;48:1511–1523. doi: 10.1016/j.jbiomech.2015.02.065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Rechberger T, Uldbjerg N, Oxlund H. Connective tissue changes in the cervix during normal pregnancy and pregnancy complicated by cervical incompetence. Obstet Gynecol. 1988;71:563–567. [PubMed] [Google Scholar]
  • 72.Myers KM, et al. A continuous fiber distribution material model for human cervical tissue. J. Biomech. 2015;48:1533–1540. doi: 10.1016/j.jbiomech.2015.02.060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Bergholt MS, et al. Fiber-optic Raman spectroscopy probes gastric carcinogenesis in vivo at endoscopy. J Biophotonics. 2013;6:49–59. doi: 10.1002/jbio.201200138. [DOI] [PubMed] [Google Scholar]
  • 74.Matousek P, et al. Subsurface probing in diffusely scattering media using spatially offset Raman spectroscopy. Applied spectroscopy. 2005;59:393–400. doi: 10.1366/0003702053641450. [DOI] [PubMed] [Google Scholar]
  • 75.Hanlon EB, et al. Prospects for in vivo Raman spectroscopy. Physics in Medicine and Biology. 2000;45:R1–59. doi: 10.1088/0031-9155/45/2/201. [DOI] [PubMed] [Google Scholar]
  • 76.Pence I, Mahadevan-Jansen A. Clinical instrumentation and applications of Raman spectroscopy. Chemical Society reviews. 2016;45:1958–1979. doi: 10.1039/C5CS00581G. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Chakraborty I, Das SK, Wang J, Dey SK. Developmental expression of the cyclo-oxygenase-1 and cyclo-oxygenase-2 genes in the peri-implantation mouse uterus and their differential regulation by the blastocyst and ovarian steroids. J. Mol. Endocrinol. 1996;16:107–122. doi: 10.1677/jme.0.0160107. [DOI] [PubMed] [Google Scholar]
  • 78.Herington JL, et al. High-Throughput Screening of Myometrial Calcium-Mobilization to Identify Modulators of Uterine Contractility. PLoS One. 2015;10:e0143243. doi: 10.1371/journal.pone.0143243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Lieber CA, Mahadevan-Jansen A. Automated method for subtraction of fluorescence from biological Raman spectra. Applied spectroscopy. 2003;57:1363–1367. doi: 10.1366/000370203322554518. [DOI] [PubMed] [Google Scholar]
  • 80.Shafer-Peltier KE, et al. Raman microspectroscopic model of human breast tissue: implications for breast cancer diagnosis in vivo. Journal of Raman Spectroscopy. 2002;33:552–563. doi: 10.1002/jrs.877. [DOI] [Google Scholar]
  • 81.Haka AS, et al. Diagnosing breast cancer by using Raman spectroscopy. Proceedings of the National Academy of Sciences of the United States of America. 2005;102:12371–12376. doi: 10.1073/pnas.0501390102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Jain R, et al. Raman spectroscopy enables noninvasive biochemical characterization and identification of the stage of healing of a wound. Anal. Chem. 2014;86:3764–3772. doi: 10.1021/ac500513t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Korhonen, R. & Saarakkala, S. Biomechanics and Modeling of Skeletal Soft Tissues (2011).
  • 84.Rasmussen LE, Buss IO, Hess DL, Schmidt MJ. Testosterone and dihydrotestosterone concentrations in elephant serum and temporal gland secretions. Biol Reprod. 1984;30:352–362. doi: 10.1095/biolreprod30.2.352. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Figures (138.3KB, pdf)

Data Availability Statement

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES